
Oncologist

No OPD information available
Autism Spectrum Disorder
Colorectal Cancer
Testicular Cancer
Adult Soft Tissue Sarcoma
Angiosarcoma
Breast Cancer
Chondrosarcoma
Febrile Neutropenia
Gastroesophageal Junction Cancer
Head and Neck Squamous Cell Carcinoma (HNSCC)
Hypogonadism
Lung Cancer
Magnesium Deficiency
Metabolic Syndrome
Multiple Sclerosis (MS)
Myelodysplastic Syndrome (MDS)
Non-Small Cell Lung Cancer (NSCLC)
Orthostatic Hypotension
Pancreatic Cancer
Peripheral Neuropathy
Pneumonia
Small Cell Lung Cancer (SCLC)
Stomach Cancer
Nimit Singhal is a male healthcare professional who helps people with various health conditions such as autism, cancer, and neurological disorders. He is skilled in treating different types of cancer like colorectal, testicular, breast, lung, and stomach cancer. Nimit also assists patients with conditions like multiple sclerosis, pneumonia, and metabolic syndrome.
Nimit Singhal uses special treatments and techniques to care for his patients. He communicates clearly and compassionately with patients, earning their trust through his expertise and kindness. Patients rely on him because he listens to their concerns and provides personalized care.
To stay updated with the latest medical knowledge, Nimit Singhal regularly reads research articles and attends conferences. He values learning and applies new information to improve patient care. Nimit collaborates with colleagues and other medical professionals to exchange ideas and enhance patient outcomes.
Nimit Singhal's work has positively impacted many patients' lives. His research on combining chemotherapy and intra-tumoural injections for pancreatic cancer has shown promising results in reducing tumour vascularity. In a clinical trial involving positron emission tomography imaging for neuroendocrine tumors, Nimit's contributions have advanced medical understanding and treatment options.
Through his dedication and expertise, Nimit Singhal continues to make a significant difference in the lives of his patients. His commitment to staying informed, collaborating with peers, and conducting research demonstrates his passion for providing high-quality healthcare.
Enrollment Status: Completed
Published: February 12, 2025
Intervention Type: Drug
Study Drug: 64Cu-SARTATE
Study Phase: Phase 2
